{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:31:50Z","timestamp":1787232710492,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative hematoma requiring reoperation is a clinically significant complication in breast surgery. Although tranexamic acid (TXA) is widely used in other surgical specialties to reduce bleeding, its routine use in breast surgery remains limited due to insufficient evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether intraoperative TXA reduces the incidence of hematoma following reduction mammaplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, single-center cohort study including 656 consecutive patients who underwent reduction mammaplasty between 2019 and 2024. TXA was administered intravenously (n = 124, 43%), topically (n = 124, 43%), or via both routes (n = 39, 14%) according to surgeon preference. Patients exposed to TXA were compared with those unexposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TXA use was associated with a significantly lower rate of postoperative hematomas requiring reoperation (2.1% vs. 5.1%; OR 2.3, 95% CI: 1.1\u20135.0;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.042). Operative time was longer in the TXA group (133 vs. 122 minutes;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001), and patients receiving TXA had higher intraoperative blood loss and breast resection weights. No significant differences were observed in overall complications or 30-day reoperation rates, although superficial infections were more frequent in the non-TXA group (3.8% vs. 0.7%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.022). Multivariable analysis suggested a trend toward TXA as an independent protective factor. No TXA-related adverse events were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intraoperative TXA in reduction mammaplasty was associated with a more than twofold reduction in postoperative hematomas. As a simple and low-risk intervention, TXA may reduce the need for reoperation. Large randomized controlled trials are warranted to confirm these findings and guide definitive clinical recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence III<\/jats:title>\n                    <jats:p>\n                      This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.springer.com\/00266\" ext-link-type=\"uri\">www.springer.com\/00266<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00266-026-06101-w","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:58:23Z","timestamp":1781546303000},"page":"6074-6081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Tranexamic Acid to Reduce Postoperative Hematoma in Reduction Mammaplasty: A Retrospective Analysis of 656 Patients"],"prefix":"10.1007","volume":"50","author":[{"given":"Joni","family":"Ilmanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-6870","authenticated-orcid":false,"given":"Salvatore","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"5","key":"6101_CR1","doi-asserted-by":"publisher","first-page":"829e","DOI":"10.1097\/PRS.0b013e31824a2efc","volume":"129","author":"DC Hammond","year":"2012","unstructured":"Hammond DC, Loffredo M. Breast reduction. Plast Reconstr Surg. 2012;129(5):829e\u201339e. https:\/\/doi.org\/10.1097\/PRS.0b013e31824a2efc.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"6101_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/jcm14010151","volume":"14","author":"S Magni","year":"2024","unstructured":"Magni S, Guggenheim L, Fournier G, et al. The effects of systemic tranexamic acid administration on drainage volume, length of hospital stay, and postoperative complications in reduction mammaplasty. J Clin Med. 2024;14(1):151\u2013151. https:\/\/doi.org\/10.3390\/jcm14010151.","journal-title":"J Clin Med"},{"issue":"5","key":"6101_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/PRS.0000000000010071","volume":"151","author":"R Liechti","year":"2023","unstructured":"Liechti R, Van De Wall BJM, Hug U, Fritsche E, Franchi A. Tranexamic acid use in breast surgery: a systematic review and meta-analysis. Plast Reconstr Surg. 2023;151(5):949\u201357. https:\/\/doi.org\/10.1097\/PRS.0000000000010071.","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"6101_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/jcm12020642","volume":"12","author":"N Holopainen","year":"2023","unstructured":"Holopainen N, Oranges CM, Di Summa PG, Toia F, Giordano S. Return to work after breast reduction: a comparative study. J Clin Med. 2023;12(2):642. https:\/\/doi.org\/10.3390\/jcm12020642.","journal-title":"J Clin Med"},{"key":"6101_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.bjps.2024.10.011","volume":"99","author":"KO Sadiq","year":"2024","unstructured":"Sadiq KO, Ruiz Cota P, Creamer R, Mahedia M, Dobke MK. Reduction mammaplasty relieves depression in women with macromastia: a systematic review. J Plast Reconstr Aesthet Surg. 2024;99:502\u20135. https:\/\/doi.org\/10.1016\/j.bjps.2024.10.011.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"12","key":"6101_CR6","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.bjps.2007.09.024","volume":"61","author":"KMM Saariniemi","year":"2008","unstructured":"Saariniemi KMM, Keranen UH, Salminen-Peltola PK, Kuokkanen HOM. Reduction mammaplasty is effective treatment according to two quality of life instruments a prospective randomised clinical trial. J Plast Reconstr Aesthet Surg. 2008;61(12):1472\u20138. https:\/\/doi.org\/10.1016\/j.bjps.2007.09.024.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"2","key":"6101_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00266-017-1009-6","volume":"42","author":"IV Cabral","year":"2018","unstructured":"Cabral IV, Da Silva Garcia E, Sobrinho RN, et al. Use of the BREAST-Q\u2122 survey in the prospective evaluation of reduction mammaplasty outcomes. Aesthetic Plast Surg. 2018;42(2):388\u201395. https:\/\/doi.org\/10.1007\/s00266-017-1009-6.","journal-title":"Aesthetic Plast Surg"},{"key":"6101_CR8","volume":"19","author":"J Bai","year":"2019","unstructured":"Bai J, Rosen CM, Ngaage LM, et al. Longevity of outcomes following reduction mammoplasty. Eplasty. 2019;19:e18.","journal-title":"Eplasty"},{"issue":"5","key":"6101_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/PRS.0000000000006114","volume":"144","author":"TA Crittenden","year":"2019","unstructured":"Crittenden TA, Watson DI, Ratcliffe J, Griffin PA, Dean NR. Outcomes of breast reduction surgery using the BREAST-Q: a prospective study and comparison with normative data. Plast Reconstr Surg. 2019;144(5):1034\u201344. https:\/\/doi.org\/10.1097\/PRS.0000000000006114.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"6101_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00266-024-04239-z","volume":"49","author":"D Boccara","year":"2025","unstructured":"Boccara D, Chaouat M, Mimoun M, Kaplan J, Serror K, Couteau C. Reduction mammoplasties: risk factors and early complications\u2014about 1442 cases. Aesthetic Plast Surg. 2025;49(1):211\u201323. https:\/\/doi.org\/10.1007\/s00266-024-04239-z.","journal-title":"Aesthetic Plast Surg"},{"key":"6101_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bjps.2023.04.039","volume":"83","author":"K Sipos","year":"2023","unstructured":"Sipos K, K\u00e4m\u00e4r\u00e4inen S, Kauhanen S. Topical tranexamic acid reduces postoperative hematomas in reduction mammaplasties. J Plast Reconstr Aesthet Surg. 2023;83:172\u20139. https:\/\/doi.org\/10.1016\/j.bjps.2023.04.039.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"6101_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojaf035","author":"ZA Alhebshi","year":"2025","unstructured":"Alhebshi ZA, Sabbagh SR, AlQurain ZJ, et al. The role of tranexamic acid use in reduction mammaplasty: a systematic review and meta-analysis. Aesthet Surg J Open Forum. 2025. https:\/\/doi.org\/10.1093\/asjof\/ojaf035.","journal-title":"Aesthet Surg J Open Forum."},{"issue":"1","key":"6101_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s40001-025-02723-z","volume":"30","author":"R Ran","year":"2025","unstructured":"Ran R, Wang H, He X, et al. Risk factors for complications after reduction mammaplasty: a systematic review and meta-analysis. Eur J Med Res. 2025;30(1):440. https:\/\/doi.org\/10.1186\/s40001-025-02723-z.","journal-title":"Eur J Med Res"},{"issue":"5","key":"6101_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/XCS.0000000000000926","volume":"238","author":"K Stanek","year":"2024","unstructured":"Stanek K, Nussbaum L, Labow BI, et al. Understanding hematoma risk: study of patient and perioperative factors in a large cohort of young women undergoing reduction mammaplasty. J Am Coll Surg. 2024;238(5):900\u201310. https:\/\/doi.org\/10.1097\/XCS.0000000000000926.","journal-title":"J Am Coll Surg"},{"key":"6101_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-025-05052-y","author":"E Fung","year":"2025","unstructured":"Fung E, Montalmant KE, Roth JM, et al. Utility of tranexamic acid in reduction mammaplasty: a systematic review and meta-analysis. Aesthetic Plast Surg. 2025. https:\/\/doi.org\/10.1007\/s00266-025-05052-y.","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"6101_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1457496914526872","volume":"104","author":"A Carpelan","year":"2015","unstructured":"Carpelan A, Kauhanen S, Mattila K, Jahkola T, Tukiainen E. Reduction mammaplasty as an outpatient procedure: a retrospective analysis of outcome and success rate. Scand J Surg. 2015;104(2):96\u2013102. https:\/\/doi.org\/10.1177\/1457496914526872.","journal-title":"Scand J Surg."},{"issue":"4","key":"6101_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bpa.2023.11.006","volume":"37","author":"N Relke","year":"2023","unstructured":"Relke N, Tang GH, Sholzberg M. Intra-operative tranexamic acid: A standard of care? Best Pract Res Clin Anaesthesiol. 2023;37(4):468\u201376. https:\/\/doi.org\/10.1016\/j.bpa.2023.11.006.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"6101_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojae077","author":"TE Habarth-Morales","year":"2024","unstructured":"Habarth-Morales TE, Isch E, Zavitsanos AP, et al. The use of tranexamic acid in breast reduction and abdominoplasty: a review of a multicenter federated electronic health record database. Aesthetic Surg J Open Forum. 2024. https:\/\/doi.org\/10.1093\/asjof\/ojae077.","journal-title":"Aesthetic Surg J Open Forum."},{"issue":"3","key":"6101_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/SAP.0000000000004184","volume":"94","author":"A Pontes","year":"2025","unstructured":"Pontes A, Barreiro D, Costa-Ferreira A. The impact of tranexamic acid administration in reduction mammaplasty: a systematic review. Ann Plast Surg. 2025;94(3):370\u20137. https:\/\/doi.org\/10.1097\/SAP.0000000000004184.","journal-title":"Ann Plast Surg"},{"issue":"1","key":"6101_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0304-4165(81)90312-3","volume":"673","author":"M Hoylaerts","year":"1981","unstructured":"Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981;673(1):75\u201385.","journal-title":"Biochim Biophys Acta"},{"issue":"s1","key":"6101_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/anae.12910","volume":"70","author":"BJ Hunt","year":"2015","unstructured":"Hunt BJ. The current place of tranexamic acid in the management of bleeding. Anaesthesia. 2015;70(s1):50. https:\/\/doi.org\/10.1111\/anae.12910.","journal-title":"Anaesthesia"},{"issue":"6S","key":"6101_CR22","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.1097\/SAP.0000000000003296","volume":"90","author":"A Om","year":"2023","unstructured":"Om A, Marxen T, Kebede S, Losken A. The Usage of Intravenous Tranexamic Acid in Reduction Mammaplasty Safely Reduces Hematoma Rates. Ann Plast Surg. 2023;90(6S):S371\u20134. https:\/\/doi.org\/10.1097\/SAP.0000000000003296.","journal-title":"Ann Plast Surg"},{"issue":"3","key":"6101_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tmrv.2018.02.003","volume":"32","author":"J Montroy","year":"2018","unstructured":"Montroy J, Hutton B, Moodley P, et al. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018;32(3):165\u201378. https:\/\/doi.org\/10.1016\/j.tmrv.2018.02.003.","journal-title":"Transfus Med Rev"},{"issue":"10","key":"6101_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/BOT.0000000000000919","volume":"31","author":"KM Amer","year":"2017","unstructured":"Amer KM, Rehman S, Amer K, Haydel C. Efficacy and safety of tranexamic acid in orthopaedic fracture surgery: a meta-analysis and systematic literature review. J Orthop Trauma. 2017;31(10):520\u20135. https:\/\/doi.org\/10.1097\/BOT.0000000000000919.","journal-title":"J Orthop Trauma"},{"issue":"6","key":"6101_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/asj\/sjab399","volume":"42","author":"JM Weissler","year":"2022","unstructured":"Weissler JM, Kuruoglu D, Antezana L, et al. Efficacy of tranexamic acid in reducing seroma and hematoma formation following reduction mammaplasty. Aesthet Surg J. 2022;42(6):616\u201325. https:\/\/doi.org\/10.1093\/asj\/sjab399.","journal-title":"Aesthet Surg J"},{"issue":"11","key":"6101_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/bjs.9878","volume":"102","author":"K Ausen","year":"2015","unstructured":"Ausen K, Fossmark R, Spigset O, Pleym H. Randomized clinical trial of topical tranexamic acid after reduction mammoplasty. Br J Surg. 2015;102(11):1348\u201353. https:\/\/doi.org\/10.1002\/bjs.9878.","journal-title":"Br J Surg"},{"issue":"1","key":"6101_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PRS.0000000000010952","volume":"154","author":"A Yao","year":"2024","unstructured":"Yao A, Wang F, Benacquista T, et al. Topical tranexamic acid does not reduce hematoma in reduction mammaplasty: a double-blind randomized controlled trial. Plast Reconstr Surg. 2024;154(1):30\u20137. https:\/\/doi.org\/10.1097\/PRS.0000000000010952.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"6101_CR28","doi-asserted-by":"publisher","first-page":"ojab002","DOI":"10.1093\/asjof\/ojab002","volume":"3","author":"NM Abboud","year":"2021","unstructured":"Abboud NM, Kapila AK, Abboud S, Yaacoub E, Abboud MH. The Combined effect of intravenous and topical tranexamic acid in liposuction: a randomized double-blinded controlled trial. Aesthetic Surg J Open Forum. 2021;3(1):ojab002. https:\/\/doi.org\/10.1093\/asjof\/ojab002.","journal-title":"Aesthetic Surg J Open Forum."},{"issue":"4","key":"6101_CR29","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.surge.2022.11.005","volume":"21","author":"GG Calpin","year":"2023","unstructured":"Calpin GG, McAnena PF, Davey MG, Calpin P, et al. The role of tranexamic acid in reducing post-operative bleeding and seroma formation in breast surgery: a meta-analysis. Surgeon. 2023;21(4):e183\u201394. https:\/\/doi.org\/10.1016\/j.surge.2022.11.005.","journal-title":"Surgeon"},{"issue":"6","key":"6101_CR30","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1007\/s00266-023-03387-y","volume":"47","author":"D Liu","year":"2023","unstructured":"Liu D, Wu M, Xu X, et al. Risk factors and complications in reduction mammaplasty: a systematic review and meta-analysis. Aesthetic Plast Surg. 2023;47(6):2330\u201344. https:\/\/doi.org\/10.1007\/s00266-023-03387-y.","journal-title":"Aesthetic Plast Surg"},{"key":"6101_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bjps.2025.03.022","volume":"104","author":"E Fung","year":"2025","unstructured":"Fung E, Godek M, Roth JM, Montalmant KE, Yu BZ, Henderson PW. The current state of tranexamic acid in mastectomy and breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025;104:259\u201372. https:\/\/doi.org\/10.1016\/j.bjps.2025.03.022.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"6101_CR32","doi-asserted-by":"publisher","first-page":"993e","DOI":"10.1097\/PRS.0000000000010479","volume":"152","author":"MNQ Huynh","year":"2023","unstructured":"Huynh MNQ, Wong CR, McRae MC, Voineskos S, McRae MH. The effects of tranexamic acid in breast surgery: a systematic review and meta-analysis. Plast Reconstr Surg. 2023;152(6):993e\u20131004e. https:\/\/doi.org\/10.1097\/PRS.0000000000010479.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"6101_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/22925503221120549","volume":"32","author":"K Rose","year":"2024","unstructured":"Rose K, Edalatpour A, Gunderson KA, Michelotti BF, Poore SO, Gast K. Topical tranexamic acid (TXA) decreases time to drain removal, wound healing complications, and postoperative blood loss in autologous breast reconstruction: a retrospective study. Plast Surg. 2024;32(3):395\u2013403. https:\/\/doi.org\/10.1177\/22925503221120549.","journal-title":"Plast Surg"},{"issue":"2","key":"6101_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/PRS.0000000000006967","volume":"146","author":"JM Weissler","year":"2020","unstructured":"Weissler JM, Banuelos J, Jacobson SR, et al. Intravenous tranexamic acid in implant-based breast reconstruction safely reduces hematoma without thromboembolic events. Plast Reconstr Surg. 2020;146(2):238\u201345. https:\/\/doi.org\/10.1097\/PRS.0000000000006967.","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"6101_CR35","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/anae.16058","volume":"78","author":"SEH Tsan","year":"2023","unstructured":"Tsan SEH, Viknaswaran NL, Cheong CC, et al. Prophylactic intravenous tranexamic acid and thromboembolism in non\u2010cardiac surgery: a systematic review, meta\u2010analysis and trial sequential analysis. Anaesthesia. 2023;78(9):1153\u201361. https:\/\/doi.org\/10.1111\/anae.16058.","journal-title":"Anaesthesia"},{"issue":"5","key":"6101_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jso.27391","volume":"128","author":"D Foster","year":"2023","unstructured":"Foster D, Sebro R, Garner H, et al. Intravenous tranexamic acid is associated with an increased risk of pulmonary embolism following sarcoma resection. J Surg Oncol. 2023;128(5):869\u201376. https:\/\/doi.org\/10.1002\/jso.27391.","journal-title":"J Surg Oncol"},{"issue":"6","key":"6101_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.bjane.2021.08.022","volume":"72","author":"MJ Colomina","year":"2022","unstructured":"Colomina MJ, Contreras L, Guilabert P, Koo M, Mndez E, Sabate A. Clinical use of tranexamic acid: evidences and controversies. Braz J Anesthesiol Engl Ed. 2022;72(6):795\u2013812. https:\/\/doi.org\/10.1016\/j.bjane.2021.08.022.","journal-title":"Braz J Anesthesiol Engl Ed."},{"issue":"5","key":"6101_CR38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/SAP.0000000000003635","volume":"91","author":"N Parmeshwar","year":"2023","unstructured":"Parmeshwar N, Mehta SR, Piper M. Reviewing the impact of topical and intravenous tranexamic acid use in breast plastic surgery. Ann Plast Surg. 2023;91(5):622\u20138. https:\/\/doi.org\/10.1097\/SAP.0000000000003635.","journal-title":"Ann Plast Surg"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-06101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-026-06101-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-06101-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:16:58Z","timestamp":1787231818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-026-06101-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":38,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["6101"],"URL":"https:\/\/doi.org\/10.1007\/s00266-026-06101-w","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study informed consent is not required.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}